BBWIConsumer Cyclical · Specialty RetailThe 19 Wall Street analysts covering Bath & Body Works, Inc. hold a median 12-month price target of $22 — +26.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 76 of 100 as at 19 Sept 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores Bath & Body Works, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (98): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (24): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on BBWI, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +26.4% from it.
Of the 20 most recent actions, 2 moved their price target up and 6 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 16 Sept 2026 | Argus Research | Reiterates | Hold | — |
| 9 Sept 2026 | BMO Capital | Initiates | Market Perform | $20 |
| 27 Aug 2026 | Baird | Maintains | Neutral | $25 → $23 |
| 27 Aug 2026 | Baird | Maintains | Neutral | — |
| 27 Aug 2026 | Barclays | Maintains | Equal-Weight | — |
| 27 Aug 2026 | Barclays | Maintains | Equal-Weight | $23 → $22 |
| 27 Aug 2026 | Morgan Stanley | Maintains | Equal-Weight | $22 → $20 |
| 27 Aug 2026 | Morgan Stanley | Maintains | Equal-Weight | — |
| 27 Aug 2026 | UBS | Maintains | Neutral | $19 → $17 |
| 27 Aug 2026 | UBS | Maintains | Neutral | — |
| 27 Aug 2026 | Wells Fargo | Maintains | Overweight | — |
| 27 Aug 2026 | Wells Fargo | Maintains | Overweight | $26 → $24 |
| 18 Aug 2026 | Citigroup | Upgrade | Buy | $25 |
| 18 Aug 2026 | Citigroup | Upgrade | Buy | — |
| 18 Aug 2026 | JP Morgan | Maintains | Neutral | $22 → $24 |
| 18 Aug 2026 | JP Morgan | Maintains | Neutral | — |
| 28 July 2026 | Jefferies | Maintains | Hold | — |
| 28 July 2026 | Jefferies | Maintains | Hold | $22 → $23 |
| 8 July 2026 | Goldman Sachs | Downgrade | Sell | $23 → $19 |
| 8 July 2026 | Goldman Sachs | Downgrade | Sell | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BBWI appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 18 Sept 2026, Bath & Body Works, Inc. returned −31.0% against +16.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 67% of US stocks
Cheaper than 82% of US stocks
Cheaper than 96% of US stocks
Cheaper than 52% of US stocks
Higher than 24% of US stocks
Higher than 81% of US stocks
Higher than 57% of US stocks
Higher than 63% of US stocks
Higher than 71% of US stocks
Higher than 21% of US stocks
Higher than 96% of US stocks
Higher than 80% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Bath & Body Works, Inc. has a market value of $3.5B and an enterprise value of $7.5B.
Revenue in the twelve months to 31 July 2026: $7.2B. The latest quarter shrank 2.3% year on year.
Net income over the same four quarters: $781.0M, a 10.8% net margin.
Diluted earnings per share, trailing twelve months: $3.84.
Free cash flow in the twelve months to 31 July 2026: $1.0B, after $242.0M of capital spending.
Bath & Body Works, Inc. spent $147.0M on share buybacks and $162.0M on dividends in the twelve months to 31 July 2026.
Trailing P/E: 4.5×; forward P/E: 6.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 4.60%, paying out 21% of earnings.
Bath & Body Works, Inc. employs 9,071 people — $795K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Bath & Body Works, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
On September 16th, 2026, Zacks Investment Research added Bath & Body Works, Inc. (BBWI) to its Zacks Rank #5 (Strong Sell) List, alongside AGCO and BSX. This designation reflects the firm's bearish rating on the stock.
Why it matters — A Zacks Strong Sell rating signals a widely followed negative assessment that BBWI watchers would want to monitor.
Bath & Body Works shares rose 7.5% after reporting a fiscal Q2 earnings beat, driven by stronger direct-to-consumer sales, and the company raised its fiscal 2026 outlook.
Why it matters — The earnings beat and raised fiscal 2026 guidance signal improving momentum for the company, a key indicator for BBWI shareholders.
Bath & Body Works reported better-than-expected second-quarter financial results on Wednesday and raised its FY26 EPS guidance. Following the results, some analysts slashed their forecasts for the company.
Why it matters — The news signals revised analyst expectations for Bath & Body Works following its Q2 performance and updated guidance.
Bath & Body Works reported volatile Q2 earnings, with weak store sales pressuring earnings power. However, e-commerce sales improved, international and wholesale revenues grew strongly, and the FY2026 guidance was raised slightly.
Why it matters — The report highlights a mix of persistent store-sales weakness alongside improving e-commerce and international growth, which may help shape expectations for BBWI's near-term performance.
Zacks Investment Research published a piece examining how Bath & Body Works' Q2 earnings key metrics compare with Wall Street estimates and year-ago figures, alongside its reported revenue and EPS for the quarter ended July 2026.
Why it matters — Comparing BBWI's key metrics to analyst estimates and prior-year results helps investors gauge how its latest quarter performed beyond headline revenue and EPS.
The 19 Wall Street analysts covering Bath & Body Works, Inc. have a median 12-month price target of $22, with estimates ranging from $17 to $54. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 19 analysts covering Bath & Body Works, Inc., 5 rate it a Buy, 13 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Bath & Body Works, Inc. 76 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 19 Sept 2026, Bath & Body Works, Inc. ranks 76 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (98 of 100).
No one can know that. What the data says: the median 12-month target from 19 analysts implies +26.4% from the last close, and Ticker Nerd's factor model ranks Bath & Body Works, Inc. 76 out of 100 as at 19 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Bath & Body Works, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BBWI are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $17 to $54 over the next 12 months.
Bath & Body Works, Inc. returned -31.0% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Bath & Body Works Inc. is a specialty retailer focused on personal care, body care, and home fragrance products.
The most recent item we track (Zacks Investment Research, 16 Sept 2026): "New Strong Sell Stocks for September 16th". On September 16th, 2026, Zacks Investment Research added Bath & Body Works, Inc. (BBWI) to its Zacks Rank #5 (Strong Sell) List, alongside AGCO and BSX. This designation reflects the firm's bearish rating on the stock.
Bath & Body Works Inc. is a specialty retailer focused on personal care, body care, and home fragrance products. Bath & Body Works offers a broad assortment of items including fine fragrance mists, body lotions, body creams, body wash, hand soaps, sanitizers, 3-wick candles, and home fragrance diffusers. The company sells through company-operated stores and e-commerce channels in the United States and Canada, while also reaching international customers through franchise, license, and wholesale partnerships. Its product mix is built around fragranced collections and seasonal assortments designed for everyday use across home and personal care routines. Bath & Body Works Inc. operates as a recognized consumer brand in the specialty retail market, with a business model centered on private-label merchandise, repeat purchasing, and omnichannel distribution.
CEO Mr. Daniel Heaf · 9,071 employees · United States · https://www.bbwinc.com
